Evidence map›Paper›PMID 26123615›Full record

ArticleNature communications2015

In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging.

Zhenhua Hu, Yawei Qu, Kun Wang, Xiaojun Zhang, Jiali Zha, Tianming Song, Chengpeng Bao, Haixiao Liu, Zhongliang Wang, Jing Wang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China.European journal of nuclear medicine and molecular imaging · 2022
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Radiopharmaceutical and EuJournal of nanobiotechnology · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Radionuclide-Activated Nanomaterials and Their Biomedical Applications.Angewandte Chemie (International ed. in English) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhenhua Hu1] Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China [2] Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China.
Yawei QuDepartment of Gastroenterology, General Hospital of Chinese People's Armed Police Forces, Beijing, 100039, China.
Kun Wang1] Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China [2] Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China.
Xiaojun ZhangDepartment of Nuclear Medicine, Chinese PLA General Hospital, Beijing, 100853 China.
Jiali ZhaDepartment of Gastroenterology, General Hospital of Chinese People's Armed Police Forces, Beijing, 100039, China.
Tianming SongKey Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Chengpeng BaoKey Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Haixiao LiuKey Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Zhongliang WangSchool of Life Science and Technology, Xidian University, Xi'an 710071, China.
Jing WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Zhongyu LiuAnal-colorectal Surgery Institute, No. 150 Central Hospital of PLA, Luoyang 471031, China.
Haifeng LiuDepartment of Gastroenterology, General Hospital of Chinese People's Armed Police Forces, Beijing, 100039, China.
Jie Tian1] Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China [2] Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China [3] The State Key Laboratory of Management and Control for Complex Systems, Chinese Academy of Sciences, Beijing 100190, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerenkov luminescence imaging utilizes visible photons emitted from radiopharmaceuticals to achieve in vivo optical molecular-derived signals. Since Cerenkov radiation is weak, non-optimum for tissue penetration and continuous regardless of biological interactions, it is challenging to detect this signal with a diagnostic dose. Therefore, it is challenging to achieve useful activated optical imaging for the acquisition of direct molecular information. Here we introduce a novel imaging strategy, which converts γ and Cerenkov radiation from radioisotopes into fluorescence through europium oxide nanoparticles. After a series of imaging studies, we demonstrate that this approach provides strong optical signals with high signal-to-background ratios, an ideal tissue penetration spectrum and activatable imaging ability. In comparison with present imaging techniques, it detects tumour lesions with low radioactive tracer uptake or small tumour lesions more effectively. We believe it will facilitate the development of nuclear and optical molecular imaging for new, highly sensitive imaging applications.

Indexed as

NanoparticlesAnimalsEuropiumFemaleMaleMiceMice, NudeMicroscopy, AcousticOptical ImagingRadiopharmaceuticalsEuropiumRadiopharmaceuticals

Identifiers

PMID26123615
PMCPMC4491820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.